Maharashtra: Man dies after receiving second dose of COVID-19 vaccine

Kirdat had complained of giddiness while he was seated in the waiting hall at the inoculation center.

He was then rushed to the Indira Gandhi Memorial hospital nearby, where he was declared dead.

Doctors said the exact cause of death is not known yet, but will be cleared after the post-mortem.

Kirdat had reportedly taken the first dose on January 28.

"He took his first dose a month back and there was no problem...We found out that he had blood pressure for many years. There were symptoms like swelling of feet. But here his BP was normal and oxygen was also normal," said Dr. KR Kharat.

"He was also an alcoholic. But no link can be established until we get the autopsy report," he added.

Two vaccines are currently being used in India - Covishield, which has been developed by AstraZeneca and Oxford University and manufactured by the Pune-based Serum Institute of India, and Bharat Biotech's COVAXIN.

Some other vaccines are also being considered.

Even as the central government has said that both the vaccines are safe, some possible short-term side effects have been listed by the respective companies.

People above the age of 60 years and those above 45 but with comorbidities are being vaccinated in the second phase of India's inoculation drive.

In the first phase, healthcare professionals and frontline medical staffers were given priority.

COVID-19 has infected over 1.11 crore and killed over 1.57 lakh across the country. A worrying spike in cases has been reported from several states lately.